For people with sensitivity, encountering an allergen can within seconds turn into a respiratory emergency. This is what you ...

Arrythmias were the heart conditions linked to the highest risk for death in patients admitted for severe anaphylaxis.

In a call hosted recently, Nasus Pharma (NYSE:NSRX) presented strong positive topline results from its Phase 2 clinical study ...

Glenis Scadding still remembers one of her first patients for sublingual immunotherapy, forty years later. His hay fever was so debilitating that he couldn't walk to the local train station without ...

About 1 in every 10 children and teens in the U.S. has a food allergy, an abnormal immune response to a specific food. That's roughly two kids per classroom. Food allergies have risen by 50% since ...

There is a promising new drug for the rare disease mastocytosis, which is associated with skin lesions, among other things. Researchers at the University of Basel have now been able to use artificial ...

Now 26 years old, former first-round pick Zhaire Smith spoke with PhillyVoice about his new perspective on his Sixers tenure, ...

Is it possible to train the body to resist seasonal allergies? That’s the hope promised by a new line of immunotherapy ...

USA: Researchers have found in a randomized clinical trial that using transepidermal water loss (TEWL) as a stopping ...

Hay fever sufferers have attempted various treatments and techniques. They have tried antihistamines, nasal sprays, air ...

NS002 demonstrated significantly faster time to the critical 100 pg/mL epinephrine threshold compared to EpiPen®, with a median T100 of 1.69 minutes versus 3.42 minutes (p=0.033). At 5 minutes, 88.4% ...